Groundbreaking Move for Medical Care in Asia

HSBC Life has announced upgrades to its Voluntary Health Insurance Flexi Plan, which now includes 100% coverage for eligible Histotripsy treatment expenses. This innovative procedure is set to be introduced to the public at Gleneagles Hospital Hong Kong, the first private institution in Asia to offer such a service, starting this March.

What is Histotripsy?

Histotripsy is a cutting-edge medical technology that can non-invasively eliminate tumors using focused ultrasound waves, thus eliminating the need for incisions, radiation, or needles. This method presents a revolutionary alternative when compared to traditional treatment options, as patients experience significantly reduced pain, fewer side effects, and shortened recovery times, allowing for a much more pleasant overall experience.

A Pioneer in Innovative Healthcare

Hong Kong has now positioned itself as a pioneer in innovative healthcare solutions in Asia, bolstering its reputation as a medical hub in the region. Daisy Tsang, CEO of HSBC Life Hong Kong and Macau, expressed pride in being the first insurer to fully cover this state-of-the-art treatment under the Voluntary Health Insurance Scheme, adding that it offers exciting new possibilities for patients across the private sector soon.

Significance for Liver Cancer Patients

Gleneagles Hospital Hong Kong CEO Dr. Kenneth Tsang highlighted the significance of this treatment for liver cancer patients. "As the first private hospital in Asia to provide Histotripsy, we are thrilled to offer a non-invasive option that caters especially to those who may be unfit for surgical procedures, enhancing personalized care and improving treatment outcomes," he stated.

A Significant Milestone for Healthcare

This medical revolution not only marks a significant milestone for healthcare in Hong Kong but also raises hope for countless patients seeking alternative treatment options for cancer. With a focus on less invasive methodologies and improved recovery experiences, Histotripsy treatment is set to change the landscape of cancer therapy in the region.